Skip to content
Head to head

Butterfly Network vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: BFLY · ABT

Updated 8 minutes ago

1-year performance, rebased to 100

BFLY +174.1%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories pays the highest dividend yield; Abbott Laboratories earns the most per share.
BFLYABT
Snapshot
SectorMedical DevicesMedical Devices
Last price5.40103.00
Change today-7.69%-0.84%
1-year return+132.8%-15.4%
Market cap$1.44B$178.39B
52-week range2.69 – 10.2180.89 – 126.70
Valuation
P/E (TTM)-25.7138.29
P/E percentile, own 5-yr range4th99th
P/B7.833.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)-0.313.72
Net profit (TTM)$-82.91M$6.44B
Revenue (TTM)$123.25M$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+51.7%+14.5%
Gross margin70.3%56.9%
Operating margin-46.9%13.8%
Net margin-43.6%9.7%
Free cash flow (TTM)$-27.55M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership73.4%81.2%
Insider activity (12mo)8 buy / 42 sell36 buy / 12 sell
Short interest (% of float)12.8%1.1%
Analyst consensus100% buy (6)93% buy / 7% hold (15)
Analyst price target$11 (+104%)$122 (+18%)
StockVane view
StockVane Quant RatingD (98)D (22)
Company
Employees220115,000
Founded20111900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.